Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sai Daayana"'
Autor:
Joshua W Wang, Subhashini Jagu, Chenguang Wang, Henry C Kitchener, Sai Daayana, Peter L Stern, Susana Pang, Patricia M Day, Warner K Huh, Richard B S Roden
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101576 (2014)
Antibodies specific for neutralizing epitopes in either Human papillomavirus (HPV) capsid protein L1 or L2 can mediate protection from viral challenge and thus their accurate and sensitive measurement at high throughput is likely informative for moni
Externí odkaz:
https://doaj.org/article/ccaad3a7b3c7411eb22353b9a75fde34
Autor:
Eyad Elkord, U Winters, Richard B.S. Roden, Peter L. Stern, Henry C Kitchener, Sai Daayana, Michael Pawlita
Publikováno v:
British Journal of Cancer
Background: Vulval intraepithelial neoplasia (VIN) is a premalignant condition, which is frequently associated with type HPV16 infection, and multifocal disease has high rates of surgical treatment failure. Methods: We report a phase II clinical tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7f67fc8331956a604245707fe1a3b9f
https://doi.org/10.1038/sj.bjc.6605611
https://doi.org/10.1038/sj.bjc.6605611
Autor:
Peter L. Stern, Sai Daayana, Richard Harrop, David J Sherlock, Deborah J. Burt, Adam Dangoor, Jan W. Drijfhout, Thomas D. Southgate, Eyad Elkord, Robert E. Hawkins
Publikováno v:
Cancer Immunology, Immunotherapy. 58:1657-1667
We have recently reported the results of a phase II trial in which two TroVax [modified vaccinia ankara (MVA) encoding the tumour antigen 5T4] vaccinations were given to patients both pre- and post-surgical resection of liver metastases secondary to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efdbea778e66183b5deb2810cfff8e0d
https://doi.org/10.1007/s00262-009-0674-y
https://doi.org/10.1007/s00262-009-0674-y
Autor:
Raphael P. Viscidi, Kihyuck Kwak, Anne Macgregor-Das, Sai Daayana, Patti E. Gravitt, Cornelia L. Trimble, Jessica M. Fogel, Subhashini Jagu, Richard B.S. Roden, Peter L. Stern, Joshua W. Wang, Wai Hong Wu, Henry C Kitchener
Publikováno v:
Clinical and vaccine immunology : CVI. 22(7)
Presently, the seroprevalence of human papillomavirus (HPV) minor capsid antigen L2-reactive antibody is not well understood, and no serologic standard exists for L2-specific neutralizing antibodies. Therefore, we screened a total of 1,078 serum samp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea1cfbaeb94092f006e832c771bc9df8
https://pubmed.ncbi.nlm.nih.gov/25972404
https://pubmed.ncbi.nlm.nih.gov/25972404
Publikováno v:
Journal of the Society for Gynecologic Investigation. 11:545-552
The purpose of this study was to use visual image analysis to observe changes in the morphology and composition of placental villi in pregnancies complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR).Placental biopsies from nine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb230aebb1d0ea4a72faf7276660fa8d
https://doi.org/10.1016/j.jsgi.2004.06.009
https://doi.org/10.1016/j.jsgi.2004.06.009
Autor:
Chenguang Wang, Susana Pang, Warner K. Huh, Subhashini Jagu, Henry C Kitchener, Joshua W. Wang, Patricia M. Day, Peter L. Stern, Sai Daayana, Richard B.S. Roden
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101576 (2014)
PLoS ONE
PLoS ONE
Antibodies specific for neutralizing epitopes in either Human papillomavirus (HPV) capsid protein L1 or L2 can mediate protection from viral challenge and thus their accurate and sensitive measurement at high throughput is likely informative for moni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4572e4113703d9c9d2df09301d3850
http://europepmc.org/articles/PMC4084990?pdf=render
http://europepmc.org/articles/PMC4084990?pdf=render
Publikováno v:
Photochemicalphotobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology. 10(5)
Vulval intraepithelial neoplasia (VIN) is a premalignant condition of the vulva and its incidence is increasing. The common type of VIN is associated with oncogenic types of human papilloma virus (HPV) infection. The standard modalities of treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b730609c2a7eb456c835c99bcc41dae
https://pubmed.ncbi.nlm.nih.gov/21494722
https://pubmed.ncbi.nlm.nih.gov/21494722
Autor:
Sai Daayana, U Winters, Eyad Elkord, Peter L. Stern, John T. Lear, Anne E. Tomlinson, Henry C Kitchener
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 14(16)
Purpose: High-risk human papillomavirus (HPV)-associated vulval intraepithelial neoplasia (VIN) is difficult to treat by excision or ablation because of high recurrence rates. Small studies of photodynamic therapy (PDT) and imiquimod treatments have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f15b7879104f03558f380c139df232
https://pubmed.ncbi.nlm.nih.gov/18698049
https://pubmed.ncbi.nlm.nih.gov/18698049